From: A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer
FDA Drug
aMP score
P-value
FDR
Clotrimazole
0.7
5.00E-06
4.88E-05
Triprolidine
0.69
2.00E-05
1.64E-04
Thioridazine
Mefloquine
3.00E-05
2.28E-04
Fluphenazine
0.66
1.11E-02
2.13E-02